Skip Navigation

European Heart Journal 1993 14(5):584-591;
Copyright © 1993 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by SIGURDSSON, E.
Right arrow Articles by SIGFUSSON, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SIGURDSSON, E.
Right arrow Articles by SIGFUSSON, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 The Europen Society of Cardiology

Prevalence of coronary heart disease in Icelandic Men 1968–1986

The Reykjavik Study

E. SIGURDSSON, G. THORGEIRSSON, H. SIGVALDASON and N. SIGFUSSON

Heart Preventive Clinic and Department of Medicine, Landspitalinn, National University Hospital of Iceland Reykjavik, Iceland

Received 6 July 1992; revised 18 November 1992; .

Correspondence: Nikulás Sigfússon, Heart Preventive Clinic. Lágmúla 9, 108 Reykjavik, Iceland

Abstract

The prevalence of coronary heart disease (CHD) was determined in a general population sample of 9141 Icelandic men aged 34–79 years, and the prevalence of four different forms of CHD was estimated separately: symptomatic infarction fulfilling WHO–MONICA criteria for definite myocardial infarction; myocardial infarction detected by ECG changes only (unrecognized, silent infarction); angina pectoris detected by the Rose questionnaire and associated with ECG manifestations of myocardial ischaemia, either at rest or during exercise, but no manifestations of myocardial infarction; angina pectoris without ECG changes indicative of myocardial ischaemia. The study was conducted in five stages allowing evaluation of trends from 1968–1986

Age was a major determinant of the prevalence of all forms of CHD. Thus, the prevalence of myocardial infarction (symptomatic or silent) rose from undetectable levels in the youngest age group (30–34 years) to around 12% (7% symptomatic and 5% silent) in the oldest group (75–79 years) and the prevalence of all forms of CHD rose from 4% in the youngest age group to 23% in the age group 70–74 years. Age-standardized comparison was carried out on the prevalence of the different forms of CHD at different stages of the study in 50–64-year-old men who were represented in all stages of the study. There was a gradual increase in the prevalence of myocardial infarction from 3% (symptomatic and silent combined, CI 1.9–4–8) in 1968 to 4.9% in 1986 (CI 3.9–6.1) (P<0.001). Conversely there was a statistically significant fall in the prevalence of angina pectoris, with or without ECG-manifestations of myocardial ischaemia, from 11.3% (CI 8.8–14.4) in 1968 to 5% in 1986 (CI 4.0–6.2) (P<0.001). This decrease was of sufficient magnitude to more than offset the rise in infarct prevalence, resulting in a significant fall in the prevalence of all CHD from 14.3% (CI 11.5–17.8) in 1968 to9.9% (CI 8.5–11.5) in 1986 in 50–64-year-old men. This trend is in general agreement with the previously reported decline in age-standardized mortality from CHD and the incidence of myocardial infarction in Iceland.

Key Words: Coronary heart disease • epidemiological survey • prevalence


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
A. Torabi, J. G.F. Cleland, N. K. Khan, P. H. Loh, A. L. Clark, F. Alamgir, J. L. Caplin, A. S. Rigby, and K. Goode
The timing of development and subsequent clinical course of heart failure after a myocardial infarction
Eur. Heart J., April 1, 2008; 29(7): 859 - 870.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Daly, F. Clemens, J. L. Lopez-Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al.
The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina
Eur. Heart J., June 1, 2006; 27(11): 1298 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. O. Arnar, S. Thorvaldsson, T. A. Manolio, G. Thorgeirsson, K. Kristjansson, H. Hakonarson, and K. Stefansson
Familial aggregation of atrial fibrillation in Iceland
Eur. Heart J., March 2, 2006; 27(6): 708 - 712.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Kattainen, V. Salomaa, T. Harkanen, A. Jula, R. Kaaja, Y. A. Kesaniemi, M. Kahonen, L. Moilanen, M. S. Nieminen, A. Aromaa, et al.
Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s
Eur. Heart J., February 1, 2006; 27(3): 296 - 301.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Daly, F. Clemens, J. L. Lopez Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al.
Gender Differences in the Management and Clinical Outcome of Stable Angina
Circulation, January 31, 2006; 113(4): 490 - 498.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
G. Thorgeirsson, G. Thorgeirsson, H. Sigvaldason, and J. Witteman
Risk factors for out-of-hospital cardiac arrest: the Reykjavik Study
Eur. Heart J., August 1, 2005; 26(15): 1499 - 1505.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. A. Daly, F. Clemens, J. L. L. Sendon, L. Tavazzi, E. Boersma, N. Danchin, F. Delahaye, A. Gitt, D. Julian, D. Mulcahy, et al.
The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of Stable Angina
Eur. Heart J., May 2, 2005; 26(10): 996 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
I. Gunnarsdottir, B. E Birgisdottir, I. Thorsdottir, V. Gudnason, and R. Benediktsson
Size at birth and coronary artery disease in a population with high birth weight
Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1290 - 1294.
[Abstract] [Full Text] [PDF]


Home page
Scand J Public HealthHome page
A. Kattainen, A. Reunanen, S. Koskinen, T. Martelin, P. Knekt, and A. Aromaa
Secular changes in prevalence of cardiovascular diseases in elderly Finns
Scand J Public Health, October 1, 2002; 30(4): 274 - 280.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. E Birgisdottir, I. Gunnarsdottir, I. Thorsdottir, V. Gudnason, and R. Benediktsson
Size at birth and glucose intolerance in a relatively genetically homogeneous, high-birth weight population
Am. J. Clinical Nutrition, August 1, 2002; 76(2): 399 - 403.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F C Lampe, R W Morris, P H Whincup, M Walker, S Ebrahim, and A G Shaper
Is the prevalence of coronary heart disease falling in British men?
Heart, November 1, 2001; 86(5): 499 - 505.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
U. Agnarsson, G. Thorgeirsson, H. Sigvaldason, and N. Sigfusson
Effects of Leisure-Time Physical Activity and Ventilatory Function on Risk for Stroke in Men: The Reykjavik Study
Ann Intern Med, June 15, 1999; 130(12): 987 - 990.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.